Journal of Clinical Research in Paramedical Sciences

Published by: Kowsar
Crossmark

Cardioprotective Effect of High-Intensity Aerobic Interval Training against Adriamycin-Induced Cardiac Toxicity in Rats

Khadijeh Ebrahimi ORCID 1 , * , Siroos Choobineh ORCID 2 , ** , Rahman Soori ORCID 2 and Reza Badalzadeh ORCID 3
Authors Information
1 Department of Physical Education and Sport Sciences, Marand Branch, Islamic Azad University, Marand, Iran
2 Department of Exercise Physiology, Faculty of Physical Education and Sport Sciences, University of Tehran, Tehran, Iran
3 Molecular Medicine Research Center and Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
Corresponding Authors:
Article information
  • Journal of Clinical Research in Paramedical Sciences: June 30, 2019, 8 (1); e83850
  • Published Online: March 17, 2019
  • Article Type: Research Article
  • Received: September 2, 2018
  • Revised: February 2, 2019
  • Accepted: February 4, 2019
  • DOI: 10.5812/jcrps.83850

To Cite: Ebrahimi K, Choobineh S , Soori R , Badalzadeh R. Cardioprotective Effect of High-Intensity Aerobic Interval Training against Adriamycin-Induced Cardiac Toxicity in Rats, J Clin Res Paramed Sci. 2019 ; 8(1):e83850. doi: 10.5812/jcrps.83850.

Abstract
Copyright © 2019, Journal of Clinical Research in Paramedical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
Footnotes
References
  • 1. Alkuraishy HM, Al-Gareeb AI, Al-hussaniy HA. Doxorubicin induced cardiotoxicity: Molecular mechanism and protection by conventional drugs and natural products. Int J Clin Oncol Cancer Res. 2017;2(2):31-44.
  • 2. Cao L, Zhu W, Wagar EA, Meng QH. Biomarkers for monitoring chemotherapy-induced cardiotoxicity. Crit Rev Clin Lab Sci. 2017;54(2):87-101. doi: 10.1080/10408363.2016.1261270. [PubMed: 28013560].
  • 3. Chen JJ, Wu PT, Middlekauff HR, Nguyen KL. Aerobic exercise in anthracycline-induced cardiotoxicity: A systematic review of current evidence and future directions. Am J Physiol Heart Circ Physiol. 2017;312(2):H213-22. doi: 10.1152/ajpheart.00646.2016. [PubMed: 27923793].
  • 4. Diamanti J, Mezzetti B, Giampieri F, Alvarez-Suarez JM, Quiles JL, Gonzalez-Alonso A, et al. Doxorubicin-induced oxidative stress in rats is efficiently counteracted by dietary anthocyanin differently enriched strawberry (Fragaria x ananassa Duch.). J Agric Food Chem. 2014;62(18):3935-43. doi: 10.1021/jf405721d. [PubMed: 24580025].
  • 5. Venkatesan N. Curcumin attenuation of acute adriamycin myocardial toxicity in rats. Br J Pharmacol. 1998;124(3):425-7. doi: 10.1038/sj.bjp.0701877. [PubMed: 9647462]. [PubMed Central: PMC1565424].
  • 6. Horino N, Kobayashi Y, Usui T. Elevation of lipid peroxide in children treated with a combination of chemotherapeutic agents including doxorubicin. Acta Paediatr Scand. 1983;72(4):549-51. doi: 10.1111/j.1651-2227.1983.tb09769.x. [PubMed: 6624430].
  • 7. Shirinbayan V, Roshan VD. Pretreatment effect of running exercise on HSP70 and DOX-induced cardiotoxicity. Asian Pac J Cancer Prev. 2012;13(11):5849-55. doi: 10.7314/APJCP.2012.13.11.5849. [PubMed: 23317268].
  • 8. Cardinale D, Scherrer-Crosbie M. The role of biomarkers. Anti-cancer treatments and cardiotoxicity. Elsevier; 2017. p. 281-90. doi: 10.1016/b978-0-12-802509-3.00024-8.
  • 9. Swain SM, Whaley FS, Ewer MS. Congestive heart failure in patients treated with doxorubicin: A retrospective analysis of three trials. Cancer. 2003;97(11):2869-79. doi: 10.1002/cncr.11407. [PubMed: 12767102].
  • 10. Maia TN, Araujo GBR, Teixeira JAC, Alves Junior ED, Dias KP. Cardiotoxicity of doxorubicin treatment and physical activity: A systematic review. Int J Cardiovasc Sci. 2017;30(1):70-80. doi: 10.5935/2359-4802.20170004.
  • 11. Kavazis AN, Smuder AJ, Powers SK. Effects of short-term endurance exercise training on acute doxorubicin-induced FoxO transcription in cardiac and skeletal muscle. J Appl Physiol (1985). 2014;117(3):223-30. doi: 10.1152/japplphysiol.00210.2014. [PubMed: 24947024]. [PubMed Central: PMC4347740].
  • 12. Gibala MJ, Jones AM. Physiological and performance adaptations to high-intensity interval training. Nestle Nutr Inst Workshop Ser. 2013;76:51-60. doi: 10.1159/000350256. [PubMed: 23899754].
  • 13. Guiraud T, Nigam A, Gremeaux V, Meyer P, Juneau M, Bosquet L. High-intensity interval training in cardiac rehabilitation. Sports Med. 2012;42(7):587-605. doi: 10.2165/11631910-000000000-00000. [PubMed: 22694349].
  • 14. Wang L, Gao K, Wang D. Exercise training has restorative potential on myocardial energy metabolism in rats with chronic heart failure. Iran J Basic Med Sci. 2018;21(8):818-23. doi: 10.22038/IJBMS.2018.29294.7076. [PubMed: 30186569]. [PubMed Central: PMC6118078].
  • 15. Zuhl M, Kravitz L. Hiit vs. continuous endurance training: Battle of the aerobic titans. IDEA Fit J. 2012;9(2):34-40.
  • 16. Wisloff U, Ellingsen O, Kemi OJ. High-intensity interval training to maximize cardiac benefits of exercise training? Exerc Sport Sci Rev. 2009;37(3):139-46. doi: 10.1097/JES.0b013e3181aa65fc. [PubMed: 19550205].
  • 17. Jarrett CL, D’Lugos AC, Mahmood TN, Gonzales RJ, Hale TM, Carroll CC, et al. Effect of high intensity exercise preconditioning and training on antioxidant enzymes in cardiomyocytes during doxorubicin treatment. FASEB J. 2016;30(1_supplement):lb601.
  • 18. Yagmurca M, Fadillioglu E, Erdogan H, Ucar M, Sogut S, Irmak MK. Erdosteine prevents doxorubicin-induced cardiotoxicity in rats. Pharmacol Res. 2003;48(4):377-82. doi: 10.1016/S1043-6618(03)00185-3. [PubMed: 12902208].
  • 19. Hoydal MA, Wisloff U, Kemi OJ, Ellingsen O. Running speed and maximal oxygen uptake in rats and mice: Practical implications for exercise training. Eur J Cardiovasc Prev Rehabil. 2007;14(6):753-60. doi: 10.1097/HJR.0b013e3281eacef1. [PubMed: 18043295].
  • 20. Kemp M, Donovan J, Higham H, Hooper J. Biochemical markers of myocardial injury. Br J Anaesth. 2004;93(1):63-73. doi: 10.1093/bja/aeh148. [PubMed: 15096441].
  • 21. Pizarro M, Troncoso R, Martinez GJ, Chiong M, Castro PF, Lavandero S. Basal autophagy protects cardiomyocytes from doxorubicin-induced toxicity. Toxicology. 2016;370:41-8. doi: 10.1016/j.tox.2016.09.011. [PubMed: 27666003].
  • 22. Nimbal SK, Koti BC. Effect of ethanolic extract fractions of boerhaavia diffusa in doxorubicin-induced myocardial toxicity in albino rats. J Young Pharm. 2017;9(4):545-9. doi: 10.5530/jyp.2017.9.104.
  • 23. Mantawy EM, El-Bakly WM, Esmat A, Badr AM, El-Demerdash E. Chrysin alleviates acute doxorubicin cardiotoxicity in rats via suppression of oxidative stress, inflammation and apoptosis. Eur J Pharmacol. 2014;728:107-18. doi: 10.1016/j.ejphar.2014.01.065. [PubMed: 24509133].
  • 24. El-Shitany NA, El-Haggar S, El-desoky K. Silymarin prevents adriamycin-induced cardiotoxicity and nephrotoxicity in rats. Food Chem Toxicol. 2008;46(7):2422-8. doi: 10.1016/j.fct.2008.03.033. [PubMed: 18487002].
  • 25. Félix DNM. Effects of voluntary physical activity and endurance training on cardiac mitochondrial function of rats sub-chronically treated with doxorubicin [dissertation]. University of Porto; 2013.
  • 26. Greufe SE. Effect of endurance exercise on the combination of streptoxotocin induced diabetes and doxorubicin [dissertation]. University of Northern Colorado; 2013.
  • 27. Kirkham AA, Eves ND, Shave RE, Bland KA, Bovard J, Gelmon KA, et al. The effect of an aerobic exercise bout 24 h prior to each doxorubicin treatment for breast cancer on markers of cardiotoxicity and treatment symptoms: A RCT. Breast Cancer Res Treat. 2018;167(3):719-29. doi: 10.1007/s10549-017-4554-4. [PubMed: 29110150].
  • 28. Rahimi M, Shekarforoush S, Asgari AR, Khoshbaten A, Rajabi H, Bazgir B, et al. The effect of high intensity interval training on cardioprotection against ischemia-reperfusion injury in wistar rats. EXCLI J. 2015;14:237-46. doi: 10.17179/excli2014-587. [PubMed: 26417361]. [PubMed Central: PMC4555214].
  • 29. Wisloff U, Stoylen A, Loennechen JP, Bruvold M, Rognmo O, Haram PM, et al. Superior cardiovascular effect of aerobic interval training versus moderate continuous training in heart failure patients: A randomized study. Circulation. 2007;115(24):3086-94. doi: 10.1161/CIRCULATIONAHA.106.675041. [PubMed: 17548726].
  • 30. Fu TC, Wang CH, Lin PS, Hsu CC, Cherng WJ, Huang SC, et al. Aerobic interval training improves oxygen uptake efficiency by enhancing cerebral and muscular hemodynamics in patients with heart failure. Int J Cardiol. 2013;167(1):41-50. doi: 10.1016/j.ijcard.2011.11.086. [PubMed: 22197120].
  • 31. Villelabeitia-Jaureguizar K, Vicente-Campos D, Senen AB, Jimenez VH, Garrido-Lestache MEB, Chicharro JL. Effects of high-intensity interval versus continuous exercise training on post-exercise heart rate recovery in coronary heart-disease patients. Int J Cardiol. 2017;244:17-23. doi: 10.1016/j.ijcard.2017.06.067. [PubMed: 28648356].
  • 32. MacInnis MJ, Gibala MJ. Physiological adaptations to interval training and the role of exercise intensity. J Physiol. 2017;595(9):2915-30. doi: 10.1113/JP273196. [PubMed: 27748956]. [PubMed Central: PMC5407969].
  • 33. Jiang HK, Wang YH, Sun L, He X, Zhao M, Feng ZH, et al. Aerobic interval training attenuates mitochondrial dysfunction in rats post-myocardial infarction: Roles of mitochondrial network dynamics. Int J Mol Sci. 2014;15(4):5304-22. doi: 10.3390/ijms15045304. [PubMed: 24675698]. [PubMed Central: PMC4013565].
  • 34. Octavia Y, Tocchetti CG, Gabrielson KL, Janssens S, Crijns HJ, Moens AL. Doxorubicin-induced cardiomyopathy: From molecular mechanisms to therapeutic strategies. J Mol Cell Cardiol. 2012;52(6):1213-25. doi: 10.1016/j.yjmcc.2012.03.006. [PubMed: 22465037].
  • 35. Gratia S, Kay L, Potenza L, Seffouh A, Novel-Chate V, Schnebelen C, et al. Inhibition of AMPK signalling by doxorubicin: At the crossroads of the cardiac responses to energetic, oxidative, and genotoxic stress. Cardiovasc Res. 2012;95(3):290-9. doi: 10.1093/cvr/cvs134. [PubMed: 22461523].

Featured Image:

Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments